Your browser doesn't support javascript.
loading
Ad-hVEGF165 reverses homocysteine-induced endothelial dysfunction by regulating nitric oxide system / 中华心血管病杂志
Chinese Journal of Cardiology ; (12): 432-436, 2015.
Artigo em Chinês | WPRIM | ID: wpr-328762
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the therapeutic effect of Ad-hVEGF165 on the endothelial cells dysfunction induced by homocysteine (Hcy) and related molecular mechanisms.</p><p><b>METHODS</b>Human umbilical vein endothelial cells CRL-1730 were treated with Hcy at different concentrations (0, 0.05, 1.00 mmol/L) for 24 h. The same concentration of Hcy, Ad-Track and Ad-hVEGF165 were added to the cells in the following groups blank group, Hcy0.05 group, Hcy1.00 group, Ad-Track group, Hcy0.05+Ad-Track group, Hcy1.00+Ad-Track group, Ad-hVEGF165 group, Hcy0.05+Ad-hVEGF165 group, Hcy1.00+ Ad-hVEGF165 group for 48 h. The mRNA and protein expressions of eNOS and DDAH2 were detected by real-time PCR and Western blot. The correlations of mRNA and protein expressions between endothelial nitric oxide synthase (eNOS) and dimethylarginine dimthylaminohydrolase (DDAH)2 were evaluated by Pearson correlation analysis.</p><p><b>RESULTS</b>Compared with blank group and Ad-hVEGF165 group, the mRNA and protein expressions of eNOS were decreased in Hcy0.05 group and Hcy0.05+Ad-hVEGF165 group (both P < 0.05), and the mRNA and protein expressions of DDAH2 in cells treated with 0.05 mmol/L and 1.00 mmol/L Hcy were reduced as well (all P < 0.05). DDAH2 mRNA and protein expression are increased (all P < 0.05) in Ad-hVEGF165 group compared with the blank group and Ad-Track, Hcy0.05 + Ad-hVEGF165 and Hcy0.05 group compared with Hcy0.05+Ad-Track group, Hcy1.00+Ad-hVEGF165 and Hcy1.00 group compared with Hcy1.00+Ad-Track group. The mRNA and protein expressions of eNOS and DDAH2 were uncorrelated under the effect of Hcy (r = 0.057 and 0.449, both P > 0.05) and VEGF (r = 0.284 and 0.432, both P > 0.05).</p><p><b>CONCLUSION</b>Recombinant adenovirus Ad-hVEGF165 could reverse Hcy-induced endothelial cells dysfunction via upregulating the expressions of eNOS and DDAH2.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Farmacologia / Proteínas Recombinantes / RNA Mensageiro / Células Cultivadas / Adenoviridae / Fator A de Crescimento do Endotélio Vascular / Óxido Nítrico Sintase Tipo III / Células Endoteliais da Veia Umbilical Humana / Amidoidrolases / Homocisteína Limite: Humanos Idioma: Chinês Revista: Chinese Journal of Cardiology Ano de publicação: 2015 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Farmacologia / Proteínas Recombinantes / RNA Mensageiro / Células Cultivadas / Adenoviridae / Fator A de Crescimento do Endotélio Vascular / Óxido Nítrico Sintase Tipo III / Células Endoteliais da Veia Umbilical Humana / Amidoidrolases / Homocisteína Limite: Humanos Idioma: Chinês Revista: Chinese Journal of Cardiology Ano de publicação: 2015 Tipo de documento: Artigo